miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.Zimin Liu, Jian Zhang, Xudong Liu et al.|PubMed|2016Cited by 32
CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Lin Shen, Jianwei Yang et al.|Nature Medicine|2025Cited by 29